Profile
James V. Caruso serves as the Chief Executive Officer of Cellectar Biosciences, Inc., a biotechnology company focused on cancer therapeutics. The SEC filings as of May 12, 2026 list him in the role of Chief Executive Officer for Cellectar Biosciences. Beyond this SEC context, public biographical details (education, prior positions, or other achievements) are not specified in the provided data.
| Role | President & CEO, Director |
|---|
| Notability | 60/100 |
|---|
Board memberships
- Cellectar Biosciences, Inc.
Awards & honors
- CEO of Cellectar Biosciences as of 2026 (per SEC filings)
Frequently Asked Questions
Who is CARUSO JAMES V?
James V. Caruso serves as the Chief Executive Officer of Cellectar Biosciences, Inc., a biotechnology company focused on cancer therapeutics. The SEC filings as of May 12, 2026 list him in the role of Chief Executive Officer for Cellectar Biosciences. Beyond this SEC context, public biographical details (education, prior positions, or other achievements) are not specified in th…
How many SEC Form 4 filings has CARUSO JAMES V submitted recently?
2 primary Form 4 filings in the last 90 days, covering 1 company.
Has CARUSO JAMES V been buying or selling stock?
Recorded transactions: 4 open-market purchases ($75K) and 0 open-market sales () across all tracked filings.
Where can I see all of CARUSO JAMES V's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.